Captrust Financial Advisors Novartis Ag Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Novartis Ag stock. As of the latest transaction made, Captrust Financial Advisors holds 131,045 shares of NVS stock, worth $13.7 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

131,045

Previous 129,315 1.34%

Holding current value

$13.7 Million

Previous $13.8 Million 9.49%

% of portfolio

0.05%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $183,604 - $209,139	1,730 Added 1.34%	131,045 $15.1 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $234,572 - $272,075	2,534 Added 2.0%	129,315 $13.8 Million
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $1.37 Million - $1.56 Million	-14,338 Reduced 10.16%	126,781 $12.3 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $68,925 - $75,850	747 Added 0.53%	141,119 $14.2 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $1.03 Million - $1.14 Million	10,829 Added 8.36%	140,372 $14.3 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $1.41 Million - $1.59 Million	15,196 Added 13.29%	129,543 $13.1 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $342,928 - $397,690	4,285 Added 3.89%	114,347 $10.5 Million
Q4 2022 Feb 15, 2023	SELL	$75.55 - $92.52 $56,209 - $68,834	-744 Reduced 0.67%	110,062 $9.98 Million
Q3 2022 Nov 16, 2022	BUY	$74.61 - $87.26 $1.11 Million - $1.3 Million	14,877 Added 15.51%	110,806 $8.42 Million
Q2 2022 Aug 23, 2022	SELL	$80.52 - $93.75 $612,435 - $713,062	-7,606 Reduced 7.35%	95,929 $8.11 Million
Q2 2022 Aug 16, 2022	BUY	$80.52 - $93.75 $1.37 Million - $1.6 Million	17,016 Added 19.67%	103,535 $8.75 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $131,780 - $149,069	1,645 Added 1.94%	86,519 $7.59 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $157,407 - $174,056	1,975 Added 2.38%	84,874 $7.42 Million
Q3 2021 Nov 16, 2021	BUY	$81.78 - $95.14 $368,418 - $428,605	4,505 Added 5.75%	82,899 $6.78 Million
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $229,380 - $253,357	-2,691 Reduced 3.32%	78,394 $7.15 Million
Q1 2021 May 17, 2021	BUY	$83.5 - $98.47 $280,727 - $331,056	3,362 Added 4.33%	81,085 $6.93 Million
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $176,360 - $213,317	2,259 Added 2.99%	77,723 $7.34 Million
Q3 2020 Nov 17, 2020	SELL	$82.14 - $91.0 $77,868 - $86,268	-948 Reduced 1.24%	75,464 $6.59 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $279,613 - $314,750	3,455 Added 4.74%	76,412 $6.71 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $28,974 - $40,594	410 Added 0.57%	72,957 $5.9 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $6.12 Million - $6.92 Million	72,547 New	72,547 $6.89 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Novartis Ag Transaction History